Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Autologous Adipose-derived Mesenchymal Stromal Cells in Preventing Biliary Complications After Living Donor Liver Transplant

NCT06649864 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06649864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Autologous Adipose-derived Mesenchymal Stromal Cells in Preventing Biliary Complications After Living Donor Liver Transplant
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Not yet recruiting
Start date
February 28, 2027
Completion date
June 30, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver diseases, liver transplant; complications